Guihai T. Liu
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Analysis of viral nucleic acid negativity and neuraminidase inhibitor use in children with severe influenza
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: February 12, 2026
Dynamic changes in epidemiology of common national notifiable infectious diseases among children in a single center in Beijing, 2016-2024
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: January 15, 2026
Uncovering structural determinants of peptide recognition by public and private T-cell receptors.
Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025
Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19.
Journal: Nature communications
Published: April 28, 2025
T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination.
Journal: Nature communications
Published: June 19, 2024
Proximity proteomics reveals UCH-L1 as an essential regulator of NLRP3-mediated IL-1β production in human macrophages and microglia.
Journal: Cell reports
Published: November 10, 2023
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.
Journal: iScience
Published: February 08, 2023
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.
Journal: Cell reports
Published: January 19, 2023
SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses.
Journal: Heliyon
Published: September 06, 2022
Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation.
Journal: Frontiers in immunology
Published: June 30, 2022
An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.
Journal: Nature immunology
Published: July 19, 2021
Last Updated: 09/26/2026